1204407-36-2Relevant articles and documents
NSAID-derived γ-secretase modulators. Part III: Membrane anchoring
Baumann, Stefanie,Hoettecke, Nicole,Schubenel, Robert,Baumann, Karlheinz,Schmidt, Boris
supporting information; experimental part, p. 6986 - 6990 (2010/06/19)
Selective lowering of Aβ42 levels with small-molecule substrate targeting γ-secretase modulators (sGSMs), such as some non-steroidal anti-inflammatory drugs, is a promising therapeutic approach for Alzheimer's disease. Here we present N-substit